secwatch.observer — SEC 8-K summary
======================================

Issuer:     Advanced Biomed Inc. (ADVB)
CIK:        0001941029
Form:       8-K
Filed at:   2026-03-16T23:59:59+00:00
Accession:  0001213900-26-028330
Event type: regulatory
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Advanced Biomed regains Nasdaq compliance after reverse stock split; stock remains listed
--------------------------------------------------------------------------------

- Received Panel decision on March 12, 2026 confirming compliance with Minimum Bid Price Rule.
- Reverse stock split completed Feb 20, 2026 brought closing bid price to $1.00+.
- Company will remain listed on Nasdaq subject to one-year Panel monitor under Rule 5815(d)(4)(A).
- Previously appealed delisting determination on Jan 21, 2026; hearing held Feb 17, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1941029/000121390026028330/0001213900-26-028330-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1941029/000121390026028330/ea0281688-8k_advanced.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-028330

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer